Head and neck cancer: Carcinoma of unknown primary

Topics in Magnetic Resonance Imaging

Volumn 18, Issue 4, 2007, Pages 281-292

  Donta, Theodore S ^a   Smoker, Wendy R K ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Head and neck cancer; Lymph nodes; Unknown primary

Indexed keywords

CANCER INVASION; COMPUTER ASSISTED TOMOGRAPHY; HEAD AND NECK CANCER; HUMAN; LYMPH NODE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TONSILLECTOMY; ULTRASOUND;

ADULT; CARCINOMA; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS, UNKNOWN PRIMARY;

EID: 34748895429     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/RMR.0b0113e3181570c6c     Document Type: Review

References (53)

1. Mahoney EJ, Spiegel JH. Evaluation and management of malignant cervical lymphadenopathy with an unknown primary tumor. Otolaryngol Clin North Am. 2005;38:87-97.
2. Adams JR, O'Brien CJ. Unknown primary squamous cell carcinoma of the head and neck: a review of diagnosis, treatment and outcomes. Asian J Surg. 2002;25:188-193.
3. Oen AL, de Boer MF, Hop WC, et al. Cervical metastasis from the unknown primary tumor. Eur Arch Otorhinolaryngol. 1995;252:222-228.
4. Guntinas-Lichius O, Peter Klussmann J, Dinh S, et al. Diagnostic work-up and outcome of cervical metastases from an unknown primary. Acta Otolaryngol. 2006;126:536-544.
5. National Cancer Institute online PDQ database. Metastatic squamous neck cancer with occult primary. Available at: http://www.cancer.gov/cancertopics/ pdq/treatment/metastatic-squamous-neck/HealthProfessional. Accessed September 7, 2007.
6. Doty JM, Gossman D, Kudrimoti M, et al. Analysis of unknown primary carcinomas metastatic to the neck: diagnosis, treatment, and outcomes. J Ky Med Assoc. 2006;104:57-64.
7. Feinmesser R, Miyazaki I, Cheung R, et al. Diagnosis of nasopharyngeal carcinoma by DNA amplification of tissue obtained by fine-needle aspiration. N Engl J Med. 1992;326:17-21.
8. Schmalbach CE, Miller FR. Occult primary head and neck carcinoma. Curr Oncol Rep. 2007;9:139-146.
9. Paul SA, Stoeckli SJ, von Schulthess GK, et al. FDG PET and PET/CT for the detection of the primary tumour in patients with cervical non-squamous cell carcinoma metastasis of an unknown primary. Eur Arch Otorhinolaryngol. 2007;264:189-195.
10. Lentsch EJ, Myers JN. Melanoma of the head and neck: current concepts in diagnosis and management. Laryngoscope. 2001;111:1209-1222.
11. Andryk J, Freije JE, Schultz CJ, et al. Lymphoepithelioma of the larynx. Am J Otolaryngol. 1996;17:61-63.
12. Pathmanathan R, Prasad U, Sadler R, et al. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med. 1995;333:693-698.
13. Curtin HD, Ishwaran H, Mancuso AA, et al. Comparison of CT and MR imaging in staging of neck metastases. Radiology. 1998;207:123-130.
14. King AD, Tse GM, Ahuja AT, et al. Necrosis in metastatic neck nodes: diagnostic accuracy of CT, MR imaging, and US. Radiology. 2004;230:720-726.
15. King AD, Tse GM, Yuen EH, et al. Comparison of CT and MR imaging for the detection of extranodal neoplastic spread in metastatic neck nodes. Eur J Radiol. 2004;52:264-270.
16. Sumi M, Van Cauteren M, Nakamura T. MR microimaging of benign and malignant nodes in the neck. AJR Am J Roentgenol. 2006;186:749-757.
17. Wippold FJ 2nd. Head and neck imaging: the role of CT and MRI. J Magn Reson Imaging. 2007;25:453-465.
18. Hoffman HT, Quets J, Toshiaki T, et al. Functional magnetic resonance imaging using iron oxide particles in characterizing head and neck adenopathy. Laryngoscope. 2000;110:1425-1430.
19. Mack MG, Balzer JO, Straub R, et al. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology. 2002;222:239-244.
20. Anzai Y. Superparamagnetic iron oxide nanoparticles: nodal metastases and beyond. Top Magn Reson Imaging. 2004;15:103-111.
21. Nakamura T, Sumi M. Nodal imaging in the neck: recent advances in US, CT and MR imaging of metastatic nodes. Eur Radiol. 2007;17:1235-1241.
22. Yonetsu K, Sumi M, Izumi M, et al. Contribution of Doppler sonography blood flow information to the diagnosis of metastatic cervical nodes in patients with head and neck cancer: assessment in relation to anatomic levels of the neck. AJNR Am J Neuroradiol. 2001;22:163-169.
23. Phelps ME. Inaugural article: positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci USA. 2000;97:9226-9233.
24. Miller FR, Hussey D, Beeram M, et al. Positron emission tomography in the management of unknown primary head and neck carcinoma. Arch Otolaryngol Head Neck Surg. 2005;131:626-629.
25. Zimmer LA, Branstetter BF, Nayak JV, et al. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck. Laryngoscope. 2005;115:2029-2034.
26. Sarji SA. Physiological uptake in FDG PET simulating disease. Biomed Imag Interv J. 2006;2:e59.
27. Blodgett TM, Fukui MB, Snyderman CH, et al. Combined PET-CT in the head and neck: Part 1. Physiologic, altered physiologic, and artifactual FDG uptake. Radiographics. 2005;25:897-912.
28. Fukui MB, Blodgett TM, Snyderman CH, et al. Combined PET-CT in the head and neck: Part 2. Diagnostic uses and pitfalls of oncologic imaging. Radiographics. 2005;25:913-930.
29. Menda Y, Graham MM. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers. Semin Nucl Med. 2005;35:214-219.
30. Dammann F, Horger M, Mueller-Berg M, et al. Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET. AJR Am J Roentgenol. 2005;184:1326-1331.
31. Adams S, Baum RP, Stuckensen T, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med. 1998;25:1255-1260.
32. Hafidh MA, Lacy PD, Hughes JP, et al. Evaluation of the impact of addition of PET to CT and MR scanning in the staging of patients with head and neck carcinomas. Eur Arch Otorhinolaryngol. 2006;263:853-859.
33. Schwartz DL, Rajendran J, Yueh B, et al. Staging of head and neck squamous cell cancer with extended-field FDG-PET. Arch Otolaryngol Head Neck Surg. 2003;129:1173-1178.
34. Stoeckli SJ, Mosna-Firlejczyk K, Goerres GW. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography. Eur J Nucl Med Mol Imaging. 2003;30:411-416.
35. Gutzeit A, Antoch G, Kuhl H, et al. Unknown primary tumors: detection with dual-modality PET/CT - initial experience. Radiology. 2005;234:227-234.
36. Schoder H, Yeung HW, Gonen M, et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology. 2004;231:65-72.
37. Branstetter BFT, Blodgett TM, Zimmer LA, et al. Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology. 2005;235:580-586.
38. Werner JA, Dunne AA, Myers JN. Functional anatomy of the lymphatic drainage system of the upper aerodigestive tract and its role in metastasis of squamous cell carcinoma. Head Neck. 2003;25:322-332.
39. Som PM, Curtin HD, Mancuso AA. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol. 2000;174:837-844.
40. Som PM, Curtin HD, Mancuso AA. An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg. 1999;125:388-396.
41. Ishikawa M, Anzai Y. MR imaging of lymph nodes in the head and neck. Neuroimaging Clin N Am. 2004;14:679-694.
42. de Braud F, al-Sarraf M. Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck. Semin Oncol. 1993;20:273-278.
43. Yousem DM, Som PM, Hackney DB, et al. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology. 1992;182:753-759.
44. Som PM. Lymph nodes of the neck. Radiology. 1987;165:593-600.
45. Johnson JT. A surgeon looks at cervical lymph nodes. Radiology. 1990;175:607-610.
46. Chong VF, Khoo JB, Fan YF. Imaging of the nasopharynx and skull base. Neuroimaging Clin N Am. 2004;14:695-719.
47. Ginsberg LE. MR imaging of perineural tumor spread. Neuroimaging Clin N Am. 2004;14:663-677.
48. Langman AW, Kaplan MJ, Dillon WP, et al. Radiologic assessment of tumor and the carotid artery: correlation of magnetic resonance imaging, ultrasound, and computed tomography with surgical findings. Head Neck. 1989;11:443-449.
49. Yoo GH, Hocwald E, Korkmaz H, et al. Assessment of carotid artery invasion in patients with head and neck cancer. Laryngoscope. 2000;110:386-390.
50. Million R, Cassisi N, Mancuso A. The unknown primary. In: Million R, Cassisi MJ, eds. Management of Head and Neck Cancer: a Multidisciplinary Approach. 2nd ed. Philadelphia: JB Lippincott; 1994.
51. Mendenhall WM, Mancuso AA, Parsons JT, et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck. 1998;20:739-744.
52. Righi PD, Sofferman RA. Screening unilateral tonsillectomy in the unknown primary. Laryngoscope. 1995;105:548-550.
53. Randall DA, Johnstone PA, Foss RD, et al. Tonsillectomy in diagnosis of the unknown primary tumor of the head and neck. Otolaryngol Head Neck Surg. 2000;122:52-55.